Combatcancer
2 known investors
Find your way into Combatcancer
175 people in our graph share verified history with the Combatcancer team — schools, employers, funds. One of them is your warm intro.
Chris Morrisunlockedknows Edward Bruce-White · together at Newcastle University
×11knows the team · via Newcastle University
Combat is a clinical-stage cancer treatment company focused on developing therapies for bladder and prostate cancer. The company is advised by leading urologic surgeons and oncologists specializing in robotic surgery and immunotherapy approaches.
Founders & leadership
EB
Edward Bruce-WhiteinCEO/Co-FounderEdward Bruce-White is CEO and co-founder of Combatcancer, a clinical-stage cancer treatment company developing therapies for bladder and prostate cancer. He brings over 20 years of experience in medical device product development, commercialization, and business strategy, with a background that includes managing major corporate transactions, IPOs, and M&A activities.
AM
Alberto Martinez AlbalatDirector of R&D, Founder and Chairman
Investors · 2
Frequently asked questions
- What does Combatcancer do?
- Combat is a clinical-stage cancer treatment company focused on developing therapies for bladder and prostate cancer. The company is advised by leading urologic surgeons and oncologists specializing in robotic surgery and immunotherapy approaches.
- Who founded Combatcancer?
- Combatcancer was founded by Edward Bruce-White, Alberto Martinez Albalat.
- Who are Combatcancer's investors?
- Combatcancer's investors include Oxford Technology Management, NW Angel.